Corazon Guerra
Psychiatry · Easton, PANPI 1659326437
Payments from drug & device makers
Across 121 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$363
- Lundbeck LLC$349
- Teva Pharmaceuticals USA, Inc.$284
- Validus Pharmaceuticals LLC$274
- Neurocrine Biosciences, Inc.$219
- Johnson & Johnson$170
- plus $1K from 12 others
What the payments were for
- Food & beverage$2,44490%
- Education$28710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $363 |
| Lundbeck LLC | 19 | $349 |
| Teva Pharmaceuticals USA, Inc. | 13 | $284 |
| Validus Pharmaceuticals LLC | 10 | $274 |
| Neurocrine Biosciences, Inc. | 8 | $219 |
| Johnson & Johnson | 8 | $170 |
| Otsuka America Pharmaceutical, Inc. | 4 | $169 |
| Sunovion Pharmaceuticals Inc. | 9 | $140 |
| Jazz Pharmaceuticals Inc. | 2 | $138 |
| Amarin Pharma, Inc. | 1 | $125 |
| Bausch Health US, LLC | 4 | $87 |
| Tactile Systems Technology Inc | 1 | $80 |
| Shire North American Group Inc | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $62 |
| Ironshore Pharmaceuticals Inc. | 4 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Neuronetics, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,731 in reported general payments places this provider in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 14 | $618 |
| Duloxetine Hcl | 11 | $361 |
| Quetiapine Fumarate | 20 | $272 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 29 | $213 |
| Clonazepam | 13 | $162 |
| Lorazepam | 20 | $147 |
| Sertraline Hcl | 15 | $132 |
| Alprazolam | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Easton
- Muhamad RifaiEaston$23K
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.